Skip to main content
Elanix Biotechnologies AG logo

Elanix Biotechnologies AG — Investor Relations & Filings

Ticker · ELN ISIN · DE000A0WMJQ4 LEI · 391200SYNFFL0NPAJK90 F Manufacturing
Open in API
Filings indexed 161 across all filing types
Latest filing 2019-06-25 Declaration of Voting R…
Country DE Germany
Listing F ELN

About Elanix Biotechnologies AG

https://elanixbiotechnologies.com/

Elanix Biotechnologies AG is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological, and gynecological applications. The company's core focus is on creating therapeutic solutions derived from progenitor cells. Its product development pipeline aims to provide advanced treatments for skin and tissue repair.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (WpHG). It details changes in the percentage of voting rights held by an individual (Lee Ann Laurent-Applegate) in Elanix Biotechnologies AG, specifically noting the 'Termination of the voting right agreement'. This directly corresponds to the definition of a major shareholding notification, which tracks changes in ownership thresholds. The appropriate code is MRQ (Major Shareholding Notification).
2019-06-25 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (WpHG). It reports changes in the percentage of voting rights held by a specific person/entity (Lee Ann Laurent-Applegate/Elanix) and the total number of voting rights. This directly corresponds to the definition of a major shareholding notification, which in the provided list maps to 'Major Shareholding Notification' (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure is a formal notification of crossing/reaching a threshold related to share ownership, which is the core function of an MRQ filing.
2019-06-20 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (Article 40, Section 1 of the WpHG). It reports changes in the percentage of voting rights held by an individual (Lee Ann Laurent-Applegate) in Elanix Biotechnologies AG, crossing or reaching a threshold. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Although the document mentions 'Voting Rights Announcements' in the header, the content focuses specifically on the change in shareholding percentage, making 'Major Shareholding Notification' (MRQ) the most precise fit among the provided options. It is not an AGM, 10-K, ER, or a general RNS, as it is a specific regulatory filing type concerning ownership thresholds.
2019-06-20 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting the 'Notification of Major Holdings' under German securities law (WpHG). It specifies the acquisition/disposal of shares with voting rights, the date the threshold was crossed (10 May 2019), and the resulting total voting rights percentage (12.85%). This content directly corresponds to the definition of reporting changes in significant share ownership, which aligns with the 'Major Shareholding Notification' category (MRQ). Although the header mentions 'Voting Rights Announcements', the core content is the change in major shareholding.
2019-06-20 English
Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES
Legal Proceedings Report Classification · 95% confidence The document is an 'Ad-hoc' announcement dated May 13, 2019, disclosing 'CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO' and an announcement regarding a significant share transfer by the Interim-CEO to the Chairman of the Supervisory Board. This content relates to legal issues (criminal charges) and insider/management actions (share transfer). It is not a standard financial report (10-K, IR, ER) or a formal proxy/governance document. Since it deals with legal proceedings against a former executive and significant internal governance/shareholder structure changes, it fits best under 'Legal Proceedings Report' (LTR) due to the criminal charges, or potentially 'Board/Management Information' (MANG) due to the CEO change context, or 'Regulatory Filings' (RNS) as a general disclosure under MAR. Given the primary focus is the filing of criminal charges, LTR is a strong candidate. However, the document also reports a significant share transfer by the CEO, which is often covered in DIRS or MRQ, but here it's framed as an announcement by the CEO herself. Since the core event is the filing of criminal charges, which is a legal matter, LTR is the most specific fit among the options for this type of negative operational/legal news, although RNS is a common catch-all for MAR disclosures. Given the severity and nature of the content (criminal charges), LTR is chosen over the general RNS.
2019-05-13 English
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
Board/Management Information Classification · 100% confidence The document is an 'Ad-hoc' announcement dated April 18, 2019, explicitly stating the 'NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.' This content directly relates to changes in the company's governing body structure and personnel. This aligns perfectly with the definition for Board/Management Information (MANG), which covers 'Announcement of changes in the company's board of directors or senior management.' The document is short and is a direct announcement, not a report itself.
2019-04-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.